IVD MEDICAL(01931): Executive Director Chan Siu Kee appointed as Company Secretary.

date
22:13 13/01/2026
avatar
GMT Eight
Huajian Medical (01931) announced that the following changes in the composition of the board of directors have taken effect as of January 13, 2026: Mr. Luo Jianhui resigned as executive director due to other business developments. He also resigned from other positions in the company, including Chief Financial Officer, Company Secretary, authorized representative of the company under Rule 3.05 of the Listing Rules of the Hong Kong Stock Exchange, and authorized representative of the company under Part 16 of the Companies Ordinance (Chapter 622 of the Laws of Hong Kong); Ms. Tai Yang resigned as executive director due to changes in work arrangements; Mr. Wong Sile resigned as independent non-executive director due to other business developments.
IVD MEDICAL (01931) Announcement: The company announces that the following changes to the composition of the Board of Directors have come into effect as of January 13, 2026: Mr. Luo Jianhui has resigned as an executive director due to other business developments. He has also resigned from all other positions in the company, including Chief Financial Officer, Company Secretary, Authorized Representative of the company as required by Rule 3.05 of the Listing Rules of the Hong Kong Stock Exchange, and Authorized Representative of the company as required by Section 16 of the Companies Ordinance Chapter 622 of Hong Kong; Ms. Tai Yang has resigned as an executive director due to changes in work arrangements; Mr. Huang Sile has resigned as an independent non-executive director due to other business developments. In light of the above resignations, the following changes to the Board of Directors have come into effect as of January 13, 2026: Mr. Luo Jianhui is no longer a member of the company's Compensation Committee; Ms. Tai Yang is no longer a member of the company's Nominating Committee; Mr. Huang Sile is no longer the chairman of the company's Audit Committee, Compensation Committee, and a member of the Nominating Committee; Mr. Zhang Jianlei has been appointed as the chairman of the Audit Committee and Compensation Committee; Mr. Chen Zhaoji has been appointed as a member of the Nominating Committee; Mr. Zhong Renqian and Mr. Xu Da have been appointed as members of the Compensation Committee. Furthermore, Mr. Chen Zhaoji, an executive director, has been appointed as the Company Secretary of the company, effective from January 13, 2026. Mr. Lin Xianya, the executive director and general manager of the company, has been appointed as the Authorized Representative of the company as required by Rule 3.05 of the Listing Rules and as the Authorized Representative of the company as required by Section 16 of the Companies Ordinance, effective from January 13, 2026.